Inhibitors of the HIV integrase enzyme
US7692014B2 · kind B2 · utility
0Cited by
12References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 25, 2005 |
| Grant date | Apr 6, 2010 |
| Priority date | — |
| Expiry date | Oct 30, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention is directed to compounds of formula (I),and pharmaceutically acceptable salts and solvates thereof, their synthesis, and their use as modulators or inhibitors of the human immunodeficiency virus (“HIV”) integrase enzyme.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.